Patents by Inventor Michelle BLAKE

Michelle BLAKE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Backlight for display
    Patent number: 11921373
    Abstract: A backlight includes an extended light source adapted to emit light. A reflective polarizer is disposed on the extended light source, such that for substantially normally incident light and for at least a first wavelength in a range from about 420 nanometer (nm) to about 650 nm, the reflective polarizer reflects at least 60% of the incident light having a first polarization state and transmits at least 60% of the incident light having an orthogonal second polarization state. A first prismatic film is disposed between the extended light source and the reflective polarizer. A retarder layer is disposed between the reflective polarizer and the first prismatic film, such that for substantially normally incident light at a wavelength of about 550 nm, the retarder layer has a retardance nW, where n is an integer ?1 and W is a wavelength between about 160 nm and about 300 nm.
    Type: Grant
    Filed: February 1, 2021
    Date of Patent: March 5, 2024
    Assignee: 3M INNOVATIVE PROPERTIES COMPANY
    Inventors: Kristy A. Gillette, Michelle L Toy, William Blake Kolb, Jonah Shaver, Jason S. Petaja
  • BCMA antigen binding proteins
    Patent number: 10465009
    Abstract: The present invention relates to BCMA (B-Cell Maturation Antigen) antigen binding proteins, such as antibodies, polynucleotide sequences encoding said antigen binding proteins, and compositions and methods for diagnosing and treating diseases. The present invention also relates to BCMA antibody drug conjugates and uses thereof.
    Type: Grant
    Filed: December 5, 2013
    Date of Patent: November 5, 2019
    Assignee: Amgen Inc.
    Inventors: Richard J. Armitage, Michelle Blake, William C. Fanslow, III, Jason Charles O'Neill, Gunasekaran Kannan, Jiangchun Xu, Mark Edward Tometsko, Zhulun Wang, Athena Sudom
  • BCMA Antigen binding proteins
    Patent number: 10220090
    Abstract: The present invention relates to BCMA (B-Cell Maturation Antigen) antigen binding proteins, such as antibodies, polynucleotide sequences encoding said antigen binding proteins, and compositions and methods for diagnosing and treating diseases. The present invention also relates to BCMA antibody drug conjugates.
    Type: Grant
    Filed: December 11, 2015
    Date of Patent: March 5, 2019
    Assignee: Amgen Inc.
    Inventors: Richard J. Armitage, Michelle Blake, William C. Fanslow, III, Jason Charles O'Neill, Gunasekaran Kannan, Jiangchun Xu, Mark Edward Tometsko
  • BCMA ANTIGEN BINDING PROTEINS
    Publication number: 20190008974
    Abstract: The present invention relates to BCMA (B-Cell Maturation Antigen) antigen binding proteins, such as antibodies, polynucleotide sequences encoding said antigen binding proteins, and compositions and methods for diagnosing and treating diseases. The present invention also relates to BCMA antibody drug conjugates.
    Type: Application
    Filed: December 11, 2015
    Publication date: January 10, 2019
    Applicant: Amgen Inc.
    Inventors: Richard J. ARMITAGE, Michelle BLAKE, William C. FANSLOW, III, Jason Charles O'NEILL, Gunasekaran KANNAN, Jiangchun XU, Mark Edward TOMETSKO
  • BCMA ANTIGEN BINDING PROTEINS
    Publication number: 20170165373
    Abstract: The present invention relates to BCMA (B-Cell Maturation Antigen) antigen binding proteins, such as antibodies, polynucleotide sequences encoding said antigen binding proteins, and compositions and methods for diagnosing and treating diseases. The present invention also relates to BCMA antibody drug conjugates.
    Type: Application
    Filed: December 11, 2015
    Publication date: June 15, 2017
    Applicant: Amgen Inc.
    Inventors: Richard J. ARMITAGE, Michelle BLAKE, William C. FANSLOW, III, Jason Charles O'NEILL, Gunasekaran KANNAN, Jiangchun XU, Mark Edward TOMETSKO
  • BCMA antigen binding proteins
    Patent number: 9243058
    Abstract: The present invention relates to BCMA (B-Cell Maturation Antigen) antigen binding proteins, such as antibodies, polynucleotide sequences encoding said antigen binding proteins, and compositions and methods for diagnosing and treating diseases. The present invention also relates to BCMA antibody drug conjugates.
    Type: Grant
    Filed: December 5, 2013
    Date of Patent: January 26, 2016
    Assignee: Amgen, Inc.
    Inventors: Richard J. Armitage, Michelle Blake, William C. Fanslow, III, Jason Charles O'Neill, Gunasekaran Kannan, Jiangchun Xu, Mark Edward Tometsko
  • BCMA ANTIGEN BINDING PROTEINS
    Publication number: 20150344583
    Abstract: The present invention relates to BCMA (B-Cell Maturation Antigen) antigen binding proteins, such as antibodies, polynucleotide sequences encoding said antigen binding proteins, and compositions and methods for diagnosing and treating diseases. The present invention also relates to BCMA antibody drug conjugates and uses thereof.
    Type: Application
    Filed: December 5, 2013
    Publication date: December 3, 2015
    Inventors: Richard J. ARMITAGE, Michelle BLAKE, William C. FANSLOW, III, Jason Charles O'NEILL, Gunasekaran KANNAN, Jiangchun XU, Mark Edward TOMETSKO, Zhulun WANG, Athena SUDOM
  • DIRECT STARCH TO FERMENTABLE SUGAR
    Publication number: 20150152457
    Abstract: Provided herein are compositions and methods related to the direct conversion of the starch in a ground or fractionated grain into a fermentable sugar feedstock capable of serving as a carbon source for the industrial production of one or more products by a fermenting organism. Such conversions may be performed at temperatures at or below the initial gelatinization temperature of the starch present in the grain and may utilize one or more isolatable endogenous enzymes present in certain unrefined grains.
    Type: Application
    Filed: March 13, 2013
    Publication date: June 4, 2015
    Applicant: Danisco US Inc.
    Inventors: Collette Michelle Blake, Gang Duan, Douglas Ko, Floor K. Kooy, Sung Ho Lee, Michael Jay Pepsin, Ying Qian, Matthew T. Reboli, Vivek Sharma, Jayarama K. Shetty, Bruce A. Strohm, Paula Johanna Maria Teunissen, Hongxian Xu
  • BCMA ANTIGEN BINDING PROTEINS
    Publication number: 20140161828
    Abstract: The present invention relates to BCMA (B-Cell Maturation Antigen) antigen binding proteins, such as antibodies, polynucleotide sequences encoding said antigen binding proteins, and compositions and methods for diagnosing and treating diseases. The present invention also relates to BCMA antibody drug conjugates.
    Type: Application
    Filed: December 5, 2013
    Publication date: June 12, 2014
    Applicant: AMGEN INC.
    Inventors: Richard J. ARMITAGE, Michelle BLAKE, William C. FANSLOW, III, Jason Charles O'NEILL, Gunasekaran KANNAN, Jiangchun XU, Mark Edward TOMETSKO